Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
7
×
boulder/denver blog main
boulder/denver top stories
deals
7
×
detroit blog main
7
×
detroit top stories
indiana blog main
indiana top stories
investing
7
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
fda
pfizer
cancer
alzheimer's disease
duchenne muscular dystrophy
eli lilly
merck
takeda pharmaceutical
amag pharmaceuticals
What
bio
7
×
roundup
develop
amid
bombast
cancer
caught
companies
coronavirus
debate
discussion
drug
drugs
efforts
fda
growing
meso’s
miss
pandemic
pfizer’s
pharmaceutical
presidential
promise
response
tuesday’s
typically
vaccine
viewers
ahead
alliance
alzheimer’s
approved
asco
bails
brand
branded
bridgebio
bristol
buy
calls
Language
unset
Current search:
investing
×
bio
×
" detroit blog main "
×
" boston top stories "
×
deals
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More